All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Cohort Study Links Clinical Performance Studies to Higher Recall Rates in FDA-Authorized AI Medical Devices

By

Yijun Ren, MSc, PhD1; Yi Zheng, MMed2; Daniel Windecker, MD3 et al

15d ago· 38 min readenInsight

Summary

This cohort study analyzes characteristics of FDA-authorized AI-enabled medical devices, examining clinical evidence and factors associated with FDA recalls. The study found that among 218 devices with clinical performance studies, 7.8% were recalled, while only 2.6% of those without such studies were recalled. The research highlights the importance of clinical validation for AI medical devices and identifies patterns in recall rates based on study types, DICOM adherence, and other device characteristics.

Source

bskyCohort Study Links Clinical Performance Studies to Higher Recall Rates in FDA-Authorized AI Medical Devicesjamanetwork.com

Key quotes

· 3 pulled
Clinical performance study: Studies conducted to evaluate the safety, effectiveness, and real-world performance of the AI device in a clinical setting
No 218 17 (7.8) Yes 505 13 (2.6) Missing 180 13 (7.2)
Development study: Research conducted during the design and training phase of the AI model to develop and validate its algorithms
Snippet from the RSS feed
This cohort study examines characteristics of artificial intelligence (AI)–enabled medical devices, including clinical study evidence, associated with US Food and Drug Administration (FDA) recall.

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.